Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Globus MedicalMEX:GMED 90 Shareholder Yield % is 3.97% as of Mar. 2026. GuruFocus rates MEX:GMED with a GF Score™ of 90/100 and a GF Value™ of MXN1,783.75 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Globus Medical ranks better than 79.56% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Globus Medical's Shareholder Yield % was 3.97%.
Globus Medical (MEX:GMED) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Globus Medical Shareholder Yield % Related Terms
Globus Medical Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Globus Medical's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GMED vs PEN, PODD, BRKR: Shareholder Yield % Comparison
For the Medical Devices subindustry, Globus Medical's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Globus Medical's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Globus Medical (MEX:GMED) has a Shareholder Yield % of 3.97% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Globus Medical and its competitors. According to the industry distribution chart, Globus Medical ranks #167 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 20.4%.
Is Globus Medical's Shareholder Yield % too high?
Globus Medical's current Shareholder Yield % is 3.97%. The Medical Devices & Instruments industry median Shareholder Yield % is 0.14. Globus Medical's value of 3.97% is 2735.7% above this industry median. Based on the distribution chart, Globus Medical ranks #167 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Shareholder Yield % compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #167 out of 817 companies for Shareholder Yield %. This places Globus Medical in the top 20% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.14. Globus Medical's value of 3.97% is 2735.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.14, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current Shareholder Yield % of 3.97% is 2735.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current Shareholder Yield % is 3.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,783.75, compared to a current price of MXN1,390.45 — trading 22% below its estimated fair value. The current Shareholder Yield % is 3.97% and 2735.7% above the Medical Devices & Instruments industry median of 0.14. Globus Medical's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Shareholder Yield % is 3.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,390.45 is trading 22% below its estimated GF Value™ of MXN1,783.75.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
Shareholder Yield %: 3.97%
GF Value™: MXN1,783.75 vs. price of MXN1,390.45 (22% below fair value)
Industry Position: 2735.7% above the Medical Devices & Instruments median (#167 of 817)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
90GF Score
Get the complete analysis for MEX:GMED
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 
